NLRC3 and hepatocellular carcinoma: NLRC3 is involved in CD8+T infiltration during HCC, which may be associated with the increases of CCL5 (C-C motif chemokine ligand 5) as well as CXCL9 (C-X-C motif chemokine ligand 9) (53).